Designed purely as a
laboratory compound, Methyltrenbolone was never intended for the clinical
market. The FDA has not approved the substance. Today, it is occasionally used
in the underground scene—valued for its anabolic potency but feared for its
high hepatotoxicity. PCT is mandatory, as it strongly suppresses natural
testosterone production. The substance originally comes from French
pharmaceutical research in the 1960s.
